← Evidence map

ReviewBiomarker research2026

Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets.

Xun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets. | OpenQuestion